01873 VIVA BIOTECH
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.51X | Oper Margin | 20.8% |
|---|---|---|---|
| LT Debt/Equity | 9.0% | Net Margin | 12.7% |
| Total Debt/Equity | 33.3% | Return on Equity | 5.5% |
| Price/Book | 0.94X | Return on Assets | 3.1% |
| (HKD 1.970) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 244.62 | 177.92 | -127.98 | -592.53 | 351.70 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +37.5 | +239.0 | +78.4 | -268.5 | +176.6 |
| Earnings Per Share (HKD) | 0.116 | 0.083 | -0.066 | -0.309 | 0.184 |
| Earnings Per Share Growth (%) | +39.1 | +226.2 | +78.7 | -268.1 | +163.0 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 17.00 | 23.65 | N/A | N/A | 10.71 |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 2.089 | 1.896 | 1.881 | 2.089 | 2.474 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified # | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,729 | 1,987 | -13.0 | 2,156 |
| Operating Result | 322.499 | 297.707 | +8.3 | -56.237 |
| Associates | -4.497 | -0.095 | +4,633.7 | 0 |
| Profit Before Taxation | 318.002 | 295.705 | +7.5 | -55.953 |
| Taxation | 48.735 | 73.718 | -33.9 | 43.837 |
| Profit /( Loss) After Taxation | 269.267 | 221.987 | +21.3 | -99.79 |
| Minority Interests | 49.506 | 54.693 | -9.5 | 16.323 |
| Net Profit | 219.761 | 167.294 | +31.4 | -116.113 |
| Earnings Per Share () | 0.1159 | 0.0833 | +39.1 | -0.0660 |
| Announcement Date | 2026-03-30 | 2025-03-27 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
